Loading...
The University of Chicago Header Logo
Keywords
Last Name
Institution

Phase II study of amrubicin as second-line therapy in patients with platinum-refractory small-cell lung cancer.

Ettinger DS, Jotte R, Lorigan P, Gupta V, Garbo L, Alemany C, Conkling P, Spigel DR, Dudek AZ, Shah C, Salgia R, McNally R, Renschler MF, Oliver JW. Phase II study of amrubicin as second-line therapy in patients with platinum-refractory small-cell lung cancer. J Clin Oncol. 2010 May 20; 28(15):2598-603.

View in: PubMed

collapse authors with profiles